In a large cohort of patients with early-stage NKTCL, CD56-negative NKTCL showed a significantly poorer survival outcome than CD56-positive NKTCL, regardless of the treatment strategies (16). Here, NCAM1 is linked to extranodal nasal NK/T cell lymphoma.